IgG4-related disease: A new kid on the block or an old aquaintance?

United European Gastroenterology Journal

Volumn 2, Issue 3, 2014, Pages 165-172

  Beyer, Georg ^a   Schwaiger, Theresa ^a   Lerch, Markus M ^a   Mayerle, Julia ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Autoimmune pancreatitis type 1; IgG4 related syndrome; Mikulicz s disease; Sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G4; PREDNISOLONE; RITUXIMAB;

AUTOIMMUNE HEPATITIS; AUTOIMMUNE PANCREATITIS; CHRONIC SCLEROSING AORTITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; IMMUNOGLOBULIN G4 RELATED DISEASE; KUTTNER TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MIKULICZ DISEASE; MORBUS ORMOND; MULTIFOCAL FIBROSCLEROSIS; ORBIT PSEUDOTUMOR; PRIORITY JOURNAL; REVIEW; RIEDEL THYROIDITIS; SIALOADENITIS; THYROIDITIS;

EID: 85006224564     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614532457     Document Type: Review

References (42)

1. Kamisawa T, Funata N, Hayashi Y, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 683–687.
2. Okazaki K and Umehara H. Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol 2012; 2012: 357071.
3. Khosroshahi A and Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 57–66.
4. Uchida K, Masamune A, Shimosegawa T, et al. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol 2012; 2012: 358371.
5. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol Jpn Rheum Assoc 2012; 22: 1–14.
6. Van der Neut, Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317: 1554–1557.
7. Stone JH, Zen Y and Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539–551.
8. Yamamoto M, Takahashi H and Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol 2013; 10: 148–159.
9. Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011; 46: 277–288.
10. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755–1762.
11. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102: 1646–1653.
12. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352–358.
13. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol Jpn Rheum Assoc 2012; 22: 419–425.
14. Kamisawa T, Chari ST, Lerch MM, et al. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut 2013; 62: 1373–1380.
15. Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 2011; 40: 809–814.
16. Pickartz T, Mayerle J and Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 314–323.
17. Chari ST, Kloeppel G, Zhang L, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatol Off J Int Assoc Pancreatol IAP Al 2010; 10: 664–672.
18. Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2013; 69: 269–272.
19. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504–1507.
20. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62: 1771–1776.
21. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233: 345–352.
22. Manfredi R, Frulloni L, Mantovani W, et al. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 2011; 260: 428–436.
23. Sugumar A, Levy MJ, Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 2011; 60: 666–670.
24. Nakazawa T, Naitoh I, Hayashi K, et al. Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol 2013; 19: 7661–7670.
25. Tan TJ, Ng YL, Tan D, et al. Extrapancreatic findings of IgG4-related disease. Clin Radiol 2013.
26. Yada N, Kudo M, Chung H, et al. Autoimmune hepatitis and immunoglobulin g4-associated autoimmune hepatitis. Dig Dis Basel Switz 2013; 31: 415–420.
27. Umemura T, Zen Y, Hamano H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46(Suppl 1): 48–55.
28. Yamamoto M, Takahashi H, Sugai S, et al. Clinical and pathological characteristics of Mikulicz’s disease (IgG4-related plasmacytic exocrinopathy). Autoimmun Rev 2005; 4: 195–200.
29. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Ku¨ ttner tumor) is an IgG4-associated disease. Am J Surg Pathol 2010; 34: 202–210.
30. Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res 2010; 62: 1312–1318.
31. Stone JH, Khosroshahi A, Hilgenberg A, et al. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 2009; 60: 3139–3145.
32. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359: 1403–1404.
33. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732–738.
34. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134: 706–715.
35. Cheuk W, Yuen HKL and Chan JKC. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease? Am J Surg Pathol 2007; 31: 643–645.
36. Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol 2011; 35: 26–35.
37. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol Jpn Rheum Assoc 2012; 22: 21–30.
38. Virk R, Shinagare S, Lauwers GY, et al. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease. Mod Pathol 2014; 27: 454–459.
39. Sah RP and Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management. Curr Gastroenterol Rep 2012; 14: 95–105.
40. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010; 139: 140–148 (quiz e12–13).
41. Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2012; 62: 1607–1615.
42. Kamisawa T, Okazaki K, Kawa S, et al. Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010; 45: 471–477.